Markets Technology · · 8 min read

Trump administration deploys $2 billion in quantum computing equity stakes, marking state-as-venture-capitalist pivot

D-Wave and Rigetti surge 19-22% as federal government acquires minority stakes in nine quantum firms, mirroring Intel precedent but raising questions about commercial viability and private capital displacement.

The Trump administration announced $2.013 billion in CHIPS Act funding to nine quantum computing firms on May 21, with the federal government acquiring minority equity stakes—a strategic pivot that elevates quantum computing to national security priority alongside semiconductors and AI infrastructure.

The funding package, distributed through Letters of Intent signed with the Department of Commerce, directs $1 billion to IBM, $375 million to GlobalFoundries, and roughly $100 million each to D-Wave, Rigetti, Infleqtion, Atom Computing, PsiQuantum, and Quantinuum, with Australia’s Diraq receiving $38 million. In exchange, the government receives equity proportional to funding amounts—the second deployment of this model after the August 2025 Intel deal converted $8.9 billion in grants into 433.3 million shares at $20.47 per share for a 9.9% stake.

Immediate Market Reaction
D-Wave (QBTS) premarket+19%
Rigetti (RGTI) premarket+22%
Infleqtion intraday+36%

Market response was immediate and decisive, per Rolling Out. D-Wave surged 19-25% in premarket trading while Rigetti jumped 22-24%, with Infleqtion posting the strongest single-day gain at 36%. The rally occurred despite heavy short interest—15.4% of Rigetti’s float and 14.6% of D-Wave’s float remain sold short, raising the possibility of a sustained squeeze if government backing shifts sentiment.

The Intel precedent and accidental windfall

The government-as-venture-capitalist model gained credibility from the Intel transaction, documented in an SEC filing from August 2025. That deal converted $8.9 billion in CHIPS Act grants and Secure Enclave funds into equity at $20.47 per share. Intel stock subsequently surged 20%+, pushing the government stake’s current value to approximately $36 billion—a fourfold return in nine months. The windfall has emboldened policymakers to expand the model into Quantum Computing, AI infrastructure, and advanced manufacturing.

But quantum computing presents a fundamentally different risk profile. Intel produces semiconductors at commercial scale with proven demand. Quantum firms are pre-revenue or low-revenue research operations where commercial viability remains speculative. D-Wave reported Q1 2026 revenue of $4.4 million (up 199% year-over-year) and bookings that surged 2,000% to $33.4 million, according to Rolling Out. Rigetti posted $4.4 million in Q1 revenue with a $569 million cash position. Both companies hold substantial cash—D-Wave at $588.4 million—but their combined market capitalizations exceed $7 billion, pricing in aggressive growth that has not yet materialized.

“We see this as a transformative moment for not just D-Wave, but also for quantum computing and the United States.”

— Alan Baratz, CEO of D-Wave Quantum

Geopolitical calculus and China’s quantum advantage

The funding decision is rooted in competitive pressure from China, which has deployed an estimated $16 billion in public quantum funding—roughly four times U.S. government investment to date—and accounts for approximately 60% of global quantum patent applications, per a Jefferies report cited by Investing.com. China’s centralized, state-led approach includes regional quantum hubs (dubbed “Quantum Avenue”) and direct venture capital fund deployment, creating an integrated Industrial Policy that the U.S. has historically lacked.

Commerce Secretary Howard Lutnick framed the quantum funding as an assertion of technological leadership. In a statement released by the Department of Commerce, he said the investments would “build on our domestic industry, creating thousands of high-paying American jobs while advancing American quantum capabilities.” The rhetoric mirrors language from the semiconductor and AI policy debates, treating quantum computing as a sovereignty issue rather than a pure R&D bet.

Context

The CHIPS and Science Act of 2022 allocated $50 billion for semiconductor R&D and manufacturing incentives, with $11 billion earmarked for R&D and $39 billion for manufacturing. Quantum computing funding draws from the R&D allocation, expanding the Act’s scope beyond semiconductors into adjacent critical technologies.

Private capital displacement and fiscal risk

The $2 billion quantum deployment arrives as private capital has retreated sharply from the sector. Crypto Briefing reports that U.S. quantum funding from venture capital has dropped 80%, with a single company—Photonic Inc.—raising over $200 million in May 2026, exceeding the federal allocation when considered against the capital intensity of quantum development. The government is effectively stepping in as the primary capital provider, raising the question of whether this is efficient allocation or bailout for a sector abandoned by private investors who see limited near-term returns.

Government officials acknowledged the funding may take years to generate tangible returns. Quantum computers devote the majority of computing capacity to error correction, and the industry does not expect commercially viable quantum advantage in most applications for several more years. D-Wave deployed its Cepheus-1-108Q system in April 2026 with 108 qubits and 99.1% two-qubit gate fidelity—a technical milestone, but one that translates to modest revenue ($4.4 million in Q1) relative to its $7+ billion market valuation.

U.S. vs. China Quantum Investments
Metric United States China
Public funding to date ~$6 billion ~$16 billion (est.)
Global patent share ~25% ~60%
Industrial policy model CHIPS Act equity stakes State-directed VC + regional hubs

IBM’s quantum foundry and manufacturing sovereignty

The largest single allocation—$1 billion to IBM—will fund a standalone quantum foundry company called Anderon, which IBM will match with $1 billion in cash, creating a $2 billion joint venture. The IBM announcement positions Anderon as “America’s first purpose-built quantum foundry,” designed to fabricate quantum processors domestically rather than relying on foreign supply chains. This aligns with the Trump administration’s broader manufacturing sovereignty narrative, treating quantum hardware production as critical infrastructure alongside semiconductor fabs and AI data centers.

The foundry model also addresses a practical bottleneck: quantum processors require specialized fabrication capabilities that overlap with semiconductor manufacturing but demand additional precision for qubit coherence and error correction. By co-locating quantum R&D with domestic fabrication, the administration aims to compress the timeline from research breakthrough to commercial deployment—though whether this accelerates practical quantum advantage remains speculative.

What to watch

The equity stake structure creates accountability that pure grants lack, but it also introduces fiscal risk if quantum computing fails to deliver commercial returns within the administration’s preferred timeline. Intel’s windfall has created expectations that may not be replicable in a pre-revenue sector where technical breakthroughs remain uncertain. Key indicators: whether private capital re-enters the sector following government validation, whether D-Wave and Rigetti can sustain revenue growth commensurate with their valuations, and whether China’s centralized model produces measurable quantum advantage before decentralized U.S. efforts scale. The Intel precedent suggests government equity stakes can generate returns—but only if the underlying technology reaches commercial viability before the capital runs out.